Clinical Trials Browser

Phase 2 × INDUSTRY × cobiprostone × Clear all

NCT02542215 2019-12-02

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Phase 2 Terminated

Stomatitis